Sustained-release phenylpropanolamine hydrochloride bilayer caplets containing the hydroxypropylmethylcellulose 2208 matrix. II. Effects of filling order in bilayer compression and manufacturing method of the prolonged-release layer on compactibility of bilayer caplets

Chemical and Pharmaceutical Bulletin

Volumn 48, Issue 5, 2000, Pages 678-682

  Ohmori, Shinji ^a   Makino, Tadashi ^a  

^a TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

Author keywords

Bilayer caplet; Compactibility; Convexo concave; Direct compression; Hydroxypropylmethylcellulose 2208; Lamination

Indexed keywords

PHENYLPROPANOLAMINE;

ARTICLE; DISSOLUTION; DRUG CAPSULE; DRUG GRANULATION; DRUG MANUFACTURE; PH; SUSTAINED RELEASE PREPARATION; TABLET;

EID: 0034072641     PISSN: 00092363     EISSN: None     Source Type: Journal    
DOI: 10.1248/cpb.48.678     Document Type: Article

References (25)

1. Ohmori S., Makino T., Chem. Pharm. Bull., 48, 673-677 (2000).
2. Loeffler G. F., Pharmaceutical Dosage Forms; Tablets Vol. 2. ed. by Lieberman H. A., Lachman L., Marcel Dekker, Inc., New York and Basel, 1981, pp. 451-484.
3. Nokhodchi A., Rubinstein M. H., Ford J. L., Int. J. Pharm., 126, 189-197 (1995).
4. Nokhodchi A., Ford J. L., Rowe P. H., Rubinstein M. H., J. Pharm. Pharmacol., 48, 1116-1121 (1996).
5. Nokhodchi A., Ford J. L., Rowe P. H., Rubinstein M. H., J. Pharm. Pharmacol., 48, 1122-1127 (1996).
6. Nokhodchi A., Ford J. L., Rowe P. H., Rubinstein M. H., Int. J. Pharm., 129, 21-31 (1996).
7. Malamataris S., Karidas T., Goidas P., Int. J. Pharm., 103, 205-215 (1994).
8. Malamataris S., Karidas T., Int. J. Pharm., 104, 115-123 (1994).
9. Sheskey P. J., Cabelka T. D., Pharm. Technol., 16, 60-74 (1992).
10. Sheskey P. J., Cabelka T. D., Robb R. T., Boyce B. M., Pharm. Technol., 18, 132-150 (1994).
11. Sheskey P. J., Robb R. T., Moore R. D., Boyce B. M., Drug Drug Dev. Ind. Pharm., 21, 2151-2165 (1995).
12. Li S. P., Karth M. G., Feld K. M., DiPaolo L. C., Pendharkar C. M., Williams R. O., Drug Dev. M., Pharm., 21, 571-590 (1995).
13. Karehill P. G., Glazer M., Nyström C., Int. J. Pharm., 64, 35-34 (1990).
14. Yang L., Venkatesh G., Fassihi R., Int. J. Pharm., 152, 45-52 (1997).
15. Gunsel W. C., Pharmaceutical Dosage Forms; Tablets Vol. 1, ed. by Lieberman H. A., Lachman L., Marcel Dekker, Inc., New York and Basel, 1980, pp. 187-224.
16. Fell J. T., Newton J. M., J. Pharm. Sci., 59, 688-691 (1970).
17. Nakai Y., Fukuoka E., Nakagawa H., Yukugaku Zasshi, 98, 184-190 (1978).
18. Nakagawa H., Chem. Pharm. Bull., 30, 1401-1407 (1982).
19. Mollan M. J., Jr., Chang N., Celik M., Pharm. Technol., 19, 58-70 (1995)
20. Sugimori K., Mon S., Kawashima Y., Powder Technol., 58, 259-264 (1989).
21. Matsuno M., Okano H., Yakugaku Kenkyu, 29, 45-47 (1957).
22. Nishimura K., Aoki S., Maki T., Proceedings of Standard Formulation Research Association, 1997, 38-42.
23. Kigasawa K., Iimura H., Sugimura H., Tanizaki A., Yakugaku Zasshi, 94, 1281-1285 (1974).
24. Kigasawa K., Iimura H., Sugimura H., Tanizaki A., Yakugaku Zasshi, 94, 1286-1289 (1974).
25. Kigasawa K., Iimura H., Tanizaki A., Sugimura H., Shimizu H., Yakugaku Zasshi, 95, 769-773 (1975).